![](/img/cover-not-exists.png)
31LBA MOST – My Own Specific Therapy – A multicenter, randomized, open-label, phase II trial evaluating the clinical benefit of a maintenance treatment targeting tumor molecular alterations in patients with advanced solid tumors: preliminary results from the everolimus and sorafenib cohorts
Toulmonde, M., Le Tourneau, C., Cropet, C., Italiano, A., Bertucci, F., Ray-Coquard, I., Tredan, O., Cassier, P., Seigne, C., De la Fouchardiere, C., Flechon, A., Desseigne, F., Frappaz, D., Gomez-RocVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31949-9
Date:
September, 2015
File:
PDF, 70 KB
english, 2015